A Look at Amdocs (NasdaqGS:DOX) Valuation Following New Multi-Year AI Partnership With Optimum

Amdocs (NasdaqGS:DOX) recently announced a renewed multi-year partnership with Optimum to roll out its amAIz Suite and other AI-powered solutions. This agreement highlights ongoing demand from major telecom providers for Amdocs’ technology.

See our latest analysis for Amdocs.

Amdocs’ deal with Optimum stands out as a solid example of how their AI-powered offerings are resonating with top telecom players, even as the broader sector navigates shifts in technology and customer demand. Over the past year, the stock’s total shareholder return has slipped slightly, but the company’s long-term trajectory remains intact, supported by a robust 52% five-year total shareholder return. While momentum may have faded recently, the big picture still leans positive for patient investors.

If tech innovation in telecom is on your radar, this is an ideal opportunity to check out other industry leaders using our See the full list for free..

With shares trading more than 37% below their estimated intrinsic value and nearly 26% below the consensus price target, the question now is whether Amdocs represents real value at these levels or if the market is already factoring in future growth.

Most Popular Narrative: 20.8% Undervalued

Comparing the most followed narrative’s fair value to Amdocs’ last close paints a clear picture. The narrative’s assessed fair value of $104.00 is notably higher than the recent close of $82.32, suggesting there is substantial upside potential from current levels based on the story’s underlying assumptions.

The accelerating adoption of cloud, automation, and AI/ML across telecom and media sectors is driving a multi-year wave of IT stack modernization. Amdocs is winning new large-scale modernization and migration deals in cloud, generative AI, and data services, which is expanding its total addressable market and supporting sustained topline revenue growth.

Read the complete narrative.

Wondering what powerful assumptions propel this bullish case? There is one major financial lever in these projections, and it is not just revenue. The real surprise is how profit margins and future multiples combine to push the fair value far beyond today’s market price. Want to know the full story? The numbers driving this target might catch you off guard.

Result: Fair Value of $104.00 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent industry spending cuts or greater reliance on just a few major clients could quickly dampen Amdocs’ expected growth trajectory.

Find out about the key risks to this Amdocs narrative.

Build Your Own Amdocs Narrative

If you see things differently or want to dig into the data firsthand, you can build your own take and see how the numbers stack up for yourself. Do it your way.

A good starting point is our analysis highlighting 5 key rewards investors are optimistic about regarding Amdocs.

Looking for more investment ideas?

Seeking your next smart move? Don’t let unique opportunities pass you by. These screening tools put under-the-radar stocks and fresh trends right at your fingertips.

• Grow your passive income by uncovering companies offering reliable returns using these 19 dividend stocks with yields > 3%.
• Ride the AI momentum as you pinpoint breakthroughs transforming industries through these 25 AI penny stocks.
• Capitalize on tomorrow’s technology today by spotting innovators building the future in quantum computing with these 26 quantum computing stocks.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com